92 related articles for article (PubMed ID: 21668864)
1. Retraction: Boldt J, Mengistu A, Seyfert UT, Vogt A, Hellstern P: The impact of a medium molecular weight, low molar substitution hydroxyethyl starch dissolved in a physiologically balanced electrolyte solution on blood coagulation and platelet function in vitro. Vox Sang 2007; 93: 139-144.
Mayr WR
Vox Sang; 2011 Jul; 101(1):90. PubMed ID: 21668864
[No Abstract] [Full Text] [Related]
2. The impact of a medium molecular weight, low molar substitution hydroxyethyl starch dissolved in a physiologically balanced electrolyte solution on blood coagulation and platelet function in vitro.
Boldt J; Mengistu A; Seyfert UT; Vogt A; Hellstern P
Vox Sang; 2007 Aug; 93(2):139-44. PubMed ID: 17683357
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the in vitro effects of saline, hypertonic hydroxyethyl starch, hypertonic saline, and two forms of hydroxyethyl starch on whole blood coagulation and platelet function in dogs.
Wurlod VA; Howard J; Francey T; Schweighauser A; Adamik KN
J Vet Emerg Crit Care (San Antonio); 2015; 25(4):474-87. PubMed ID: 26037241
[TBL] [Abstract][Full Text] [Related]
4. Molar substitution and C2/C6 ratio of hydroxyethyl starch: influence on blood coagulation.
von Roten I; Madjdpour C; Frascarolo P; Burmeister MA; Fisch A; Schramm S; Bombeli T; Spahn DR
Br J Anaesth; 2006 Apr; 96(4):455-63. PubMed ID: 16464978
[TBL] [Abstract][Full Text] [Related]
5. Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM.
Casutt M; Kristoffy A; Schuepfer G; Spahn DR; Konrad C
Br J Anaesth; 2010 Sep; 105(3):273-81. PubMed ID: 20659913
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of a balanced crystalloid-based and a saline-based tetrastarch solution on canine whole blood coagulation and platelet function.
Reuteler A; Axiak-Flammer S; Howard J; Adamik KN
J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):23-34. PubMed ID: 27926787
[TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
[TBL] [Abstract][Full Text] [Related]
8. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
[TBL] [Abstract][Full Text] [Related]
9. Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation.
Schaden E; Wetzel L; Kozek-Langenecker S; Thaler U; Scharbert G
Br J Anaesth; 2012 Oct; 109(4):572-7. PubMed ID: 22791802
[TBL] [Abstract][Full Text] [Related]
10. A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids.
Roche AM; James MF; Bennett-Guerrero E; Mythen MG
Anesth Analg; 2006 Apr; 102(4):1274-9. PubMed ID: 16551936
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of hydroxyethyl starch.
Jungheinrich C; Neff TA
Clin Pharmacokinet; 2005; 44(7):681-99. PubMed ID: 15966753
[TBL] [Abstract][Full Text] [Related]
12. A new plasma-adapted hydroxyethyl starch preparation: in vitro coagulation studies.
Boldt J; Mengistu A
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):394-8. PubMed ID: 20005132
[TBL] [Abstract][Full Text] [Related]
13. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations.
London MJ; Ho JS; Triedman JK; Verrier ED; Levin J; Merrick SH; Hanley FL; Browner WS; Mangano DT
J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978
[TBL] [Abstract][Full Text] [Related]
14. In vitro effect of hydroxyethyl starch 130/0.42 on canine platelet function.
Classen J; Adamik KN; Weber K; Rubenbauer S; Hartmann K
Am J Vet Res; 2012 Dec; 73(12):1908-12. PubMed ID: 23176416
[TBL] [Abstract][Full Text] [Related]
15. Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics?
Madjdpour C; Dettori N; Frascarolo P; Burki M; Boll M; Fisch A; Bombeli T; Spahn DR
Br J Anaesth; 2005 May; 94(5):569-76. PubMed ID: 15734780
[TBL] [Abstract][Full Text] [Related]
16. Editor's note: notice of retraction.
Shafer SL
Anesth Analg; 2014 Nov; 119(5):1225. PubMed ID: 25329035
[TBL] [Abstract][Full Text] [Related]
17. Changes in acid-base, electrolyte and hemoglobin concentrations during infusion of hydroxyethyl starch 130/0.42/6 : 1 in normal saline or in balanced electrolyte solution in children.
Sümpelmann R; Witt L; Brütt M; Osterkorn D; Koppert W; Osthaus WA
Paediatr Anaesth; 2010 Jan; 20(1):100-4. PubMed ID: 19968805
[TBL] [Abstract][Full Text] [Related]
18. [Properties and clinical implications of middle molecular weight low substitution hydroxyethyl starch solution].
Kotake Y
Masui; 2014 Feb; 63(2):218-31. PubMed ID: 24601124
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a waxy maize and a potato starch-based balanced hydroxyethyl starch for priming in patients undergoing coronary artery bypass grafting.
Sethi BS; Chauhan S; Bisoi AK; Kapoor PM; Kiran U; Rajput RS
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):690-7. PubMed ID: 24144628
[TBL] [Abstract][Full Text] [Related]
20. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
